Novo Nordisk Type 2 Diabetes Drug Increases Weight Loss

Jun 16, 2014

Novo Nordisk's diabetes drug Victoza appears to be an effective weight loss therapy, according to data from a late-stage clinical trial. In a 56-week study of 846 overweight or obese adults with type 2 diabetes, a daily injection of 3 milligrams of Victoza led to significantly greater weight loss than did a placebo. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments